Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India

Clinical trial NCT07044687 · RECRUITING

Trial details

NCT number: NCT07044687
Sponsor: AbbVie
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2025-07-24
Primary completion: 2027-11-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.